Publication | Closed Access

Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases

Therapeutic EffectRadiation TherapyBrain MetastasesMedicineBronchial NeoplasmWhole Brain RadiotherapyCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences